Advances in the diagnosis and management of pulmonary arterial hypertension (PAH) have
resulted in significant improvements in outcomes for patients with this devastating and …

Recent advances in the treatment of pulmonary arterial hypertension (PAH) have led to
improved patient outcomes. Multiple PAH therapies are now available and optimising the …

Importance Pulmonary arterial hypertension (PAH) is characterized by severe remodeling of
the distal pulmonary arteries, increased pulmonary vascular resistance, and right ventricular …

Pulmonary arterial hypertension (PAH) is a rapidly progressive disease, ultimately leading to
right heart failure and death. Accumulating evidence indicates that intervention early in …

Pulmonary arterial hypertension (PAH) is a pathological condition of the small pulmonary
arteries. PAH is characterized histopathologically by vasoconstriction, vascular proliferation …

The past decade has witnessed extensive progress in basic and clinical research in the field
of pulmonary hypertension (PH), a group of chronic conditions characterised by high …

Until 20 years ago the treatment of pulmonary arterial hypertension (PAH) was based on
case reports and small series, and was largely ineffectual. As a deeper understanding of the …

In the past 2 decades, major changes have occurred in the epidemiological and treatment
landscape of pulmonary arterial hypertension (PAH). Previously regarded as a disease of …

In the summer of 2016, delegates from the German Respiratory Society, the German Society
of Cardiology and the German Society of Pediatric Cardiology met in Cologne, Germany, to …

There is a strong rationale for combining therapies to simultaneously target three of the key
pathways implicated in the pathogenesis of pulmonary arterial hypertension (PAH) …